Latest newsLATEST NEWS

We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.

2021/06/20
MVC Announces Efficacy and Safety Results of Enterovirus 71 Vaccine Phase 3 Multi-Regional and Multi-Central Clinical Trial
see more
2021/06/10
MVC Released COVID-19 Vaccine Phase 2 Interim Analysis Result
see more
2021/05/11
MVC Rolled Out COVID-19 Vaccine Booster Trial
see more
2021/05/09
MVC Completed COVID-19 Vaccine Phase 2 Interim Safety Data Review Meeting
see more
2021/04/28
MVC Announces All 3,700 Subjects in COVID-19 Vaccine Phase 2 Clinical Trial Have Completed 2nd Dose Vaccination
see more
2021/04/23
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
see more
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy & Cookie Policy contains more information on such use and explains how to disable cookies.
Agree